Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anixa Biosciences Inc Director's Dealing 2013

Jan 29, 2013

34117_dirs_2013-01-29_47915bd1-3097-497f-a70d-8a65c2b40226.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2013-01-25

Reporting Person: JOHNSON BRUCE F (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-01-25 8% Convertible Debentures Due 2015 $0.15 P Acquired 2015-01-25 Common Stock (666700) Direct
2013-01-25 Common Stock Purchase Warrant $0.3 P 333300 Acquired 2016-01-25 Common Stock (333300) Direct

Footnotes

F1: On January 25, 2013, the reporting person purchased $100,000 principal amount of Convertible Debentures and warrants to purchase 333,300 shares of Common Stock from CopyTele, Inc. in a private placement for an aggregate purchase price of $100,000